4. Architecture of MediMatch AI Decision Support & Verification Systems
Healthcare decision support in India requires bridging severe information asymmetry across multiple clinical touchpoints: from complex handwritten physician scripts and diverse state pharmacopoeial formularies to the expanding generic distribution footprint of Pradhan Mantri Bhartiya Janaushadhi Kendras. MediMatch AI operates six core clinical calculation and recognition pipelines engineered specifically for Indian healthcare infrastructure.
The Optical Character Recognition (OCR) pipeline for prescriptions utilizes multi-stage image pre-processing, including adaptive binarization, skew correction, and noise reduction. Scanned characters are mapped against a verified dictionary of more than 20,000 Indian pharmaceutical brand names and International Nonproprietary Names (INN). By cross-referencing extracted dosages with standard therapeutic windows defined in the Indian Pharmacopoeia (IP 2022) and the National Formulary of India (NFI), the system prevents dose misinterpretation and highlights Schedule H / H1 prescription prerequisites.
5. Pathology Report Analysis Methodology & Parameter Normalization
Laboratory pathology analysis requires normalizing disparate unit systems across Indian reference laboratories. The AI Lab Report Analyzer parses uploaded pathology PDFs and high-resolution camera captures, extracting analyte values for Complete Blood Counts (CBC: Hemoglobin, Total Leukocyte Count, Platelet Count, Absolute Neutrophil Count), Renal Function Tests (Serum Creatinine, Blood Urea Nitrogen, Estimated GFR), Liver Function Tests (SGOT/AST, SGPT/ALT, Alkaline Phosphatase, Total Bilirubin), and Lipid Profiles (Total Cholesterol, Triglycerides, HDL, LDL, VLDL).
Analyte concentrations are mapped against physiological baseline ranges calibrated for patient biological sex, age bracket, and clinical context. Whenever laboratory parameters breach critical clinical alert thresholds—such as acute thrombocytopenia in tropical febrile illnesses or severe renal impairment—the analyzer immediately flags contraindications for nephrotoxic or antiplatelet agents.
6. Drug Bioequivalence & Pricing Transparency Calculations
Under the statutory framework of the Indian Drugs and Cosmetics Act and Central Drugs Standard Control Organisation (CDSCO) regulations, generic pharmaceutical formulations must demonstrate in vivo bioequivalence or in vitro dissolution profile equivalence against reference innovator drugs. MediMatch AI's bioequivalence and comparison matrix correlates proprietary branded formulations with verified PMBJP generic molecules.
Generic price savings are calculated using authoritative public ceiling price orders issued by the National Pharmaceutical Pricing Authority (NPPA) under the Drugs (Prices Control) Order (DPCO). Consumers and healthcare workers can immediately determine the therapeutic comparability and direct financial savings achieved by substituting high-margin commercial brands with generic formulations procured through certified Jan Aushadhi Kendras.